A group of scientists from Rochester has discovered Resveratrol’s ability of depolarizing mitochondria constituting the primary source of energy for the cancerous cells and having their own DNA. The study showed that radiation also does not possess the ability of destroying these cancerous mitochondria membranes as effectively as Resveratrol. Chemotherapy can kill the cancer cells effectively through the process of apoptosis. However, pancreatic cancer in its advanced stage usually develops defense against the procedure of apoptosis, which makes chemotherapy absolutely ineffective. Resveratrol is capable of inducing apoptosis even in the cancer cells of advanced stage of pancreatic cancer.

Resveratrol possesses the ability of speeding up production of reactive oxygen species or ROS circulating in human body. The ROS plays the role of burning the cells. The above mentioned study on the effects of Resveratrol on pancreatic cancer revealed that when Resveratrol attacked the cancer cells in the pancreas accompanied by irradiation, the procedure of apoptosis was initiated killing the cancer cells. According to the scientists, Resveratrol can destroy cancerous cells primarily due to its ability of accelerating the production of ROS.

Fatty foods: Foods containing high amount of protein and fats must be strictly avoided by patients with pancreatic cancer. Tolerating such food items becomes extremely difficult for these cancer patients. The foods to be avoided include fatty snacks such as dips, fried chicken, nachos, potato chips, bacon, beef etc.

Foods having strong odors: One of the common consequences of pancreatic cancer is nausea. Having extremely aromatic food items might trigger nausea. Some of the food items that should be eliminated from the diet plan of a person with pancreatic cancer to make sure that the food does not contain any strong flavor include: cheese, onions, scallions, fishes etc.

Toasts and bran foods: Often in the later stages of pancreatic cancer, the patients find it difficult to swallow. In such situations, toasts and bran foods must be eliminated from their diet as these food types might appear rough to the patients’ throat. Your doctor will inform you about more food types that are likely to cause irritation in your throat.

Dairy products: Once you are diagnosed to be suffering from pancreatic cancer, you must limit your intake of dairy products. This includes milk, cheese, yogurt, etc. Consuming dairy products might result in severe digestive disorders in patients with pancreatic cancer. Also avoid consuming any food items containing dairy products as one of its ingredients; this includes ice creams, chocolates, cakes, creams etc.

Foods to be avoided for patients with radiation enteritis: Often patients undergoing treatment for pancreatic cancer develop a condition known as radiation enteritis. Radiation enteritis is a health disorder marked by swelling of small intestine due to radiation. Patient’s experience this side effect must stop taking certain food items for reducing the intensity of the disorder. The food items to be avoided by patients with radiation enteritis are: caffeinated beverages and foods, uncooked vegetables, nuts, coconut, seeds, dry fruits, whole-wheat breads and cereals etc.

Early-stage prostate cancer therapy would entail surgical intervention, radiation therapy or no therapy till the time cancer has advanced – also known as watchful waiting or active surveillance.

During watchful waiting, close monitoring is mostly done in order to identify the extent to which prostate cancer has progressed. A digital rectal examination and a periodically done blood analysis along side repeat prostate biopsy procedures were part of monitoring. In an endeavor at helping males steer clear from the need of undergoing repeated biopsies, investigators have probed for other lesser invasive actions for tracking cancer advancement.

During the recently conducted study, investigators did an evaluation of PSA levels among entrants having low-risk prostate cancer going through active surveillance for the purpose of determining if or not identification of particular measures of PSA changes like doubling time, velocity or PSA test result interpretation could be done with precision. Measurements of PSA and digital rectal examination were conducted bi-annually as part of active surveillance along with an additional yearly biopsy procedure.

• Subsequent to 2.9 years of typical follow up done on the study candidates, thirty-five percent of the males who were part of the active surveillance group were found to have an adverse biopsy procedure outcome and were suggested to go through therapy.
• Subsequent to identification, PSA test result interpretation for checking PSA change (like PSA doubling time and PSA velocity) were observed to not have high correlation with biopsy procedure outcome.

The study investigators came to a conclusion that in case of males having low-risk prostate cancer and going through active surveillance, regular surveillance biopsy continues to hold importance for identifying cancer advancement. However, an aspect to be taken into consideration is that this study conducted was a comparatively small-scaled on and carried out at a single establishment that might restrict these study outcomes from being generalized.

One such pancreatic cancer treatment that is not usually offered to individuals experiencing the later stages of pancreatic cancer is surgery.

The primary target of any type of cancer treatment is to remove the cancer. However in some cases such as that of advanced pancreatic cancer this may not be possible due to the advancement of the disease. When the cancer becomes so far advanced that surgery is no longer an alternative the focus then shifts on stopping the cancer or at the very least keeping it from spreading any further or causing any additional damage. In cases where the stage of cancer is so advanced that treatments aren’t likely to help much then steps are usually taken to treat individual symptoms and make the individual as comfortable as possible.

Although surgery is in some cases an option there are actually very few cases when it is possible to remove all of the cancer through this method. In cases that are advanced to the point where cancer has spread beyond the pancreas surgery is usually no longer offered as a method of pancreatic cancer treatment.

In the cases where surgery is offered there are generally two types of surgery that may be used. These two types include pancreatoduodenectomy and distal pancreatectomy.

A pancreatoduodenectomy is a surgical pancreatic cancer treatment that may be performed if the cancer is located in the head of the pancreas. This is often referred to as a Whipple surgery. This consists of removing the pancreas head as well as the gall bladder, and parts of the small intestine and bile duct. In some cases part of your stomach may also be removed. This surgery also poses certain risks such as bleeding, infection, temporary diabetes, nausea and vomiting.

A distal pancreatectomy is often used when tumors are located in the tail or body of the pancreas. In this procedure the tail and a small part of the body of the pancreas is removed and in some cases the spleen is also removed.

Radiation therapy is a type of treatment that may be offered when surgery is not possible. In addition radiation therapy may also be used in combination with surgery in some cases.

Chemotherapy is a treatment option in which drugs are used to destroy cancer cells and prevent them from dividing or separating. It may consist of one drug or several and may be taken orally or intravenously.

In some cases pancreatic cancer treatment may include all of these options over the course of complete treatment. Which treatment is used is determined by how advanced an individual person’s cancer may be.

Because pancreatic cancer is considered to be one of the rare types of cancer screening for this cancer is not used on everyone. It is suggested however that if you are at an increased risk for pancreatic cancer that you undergo this screening. These risk factors include a history of pancreatic cancer and certain genetic disorders.

Pancreatic cancer symptoms are often not present during the early stages of this disease which makes detection and treatment somewhat difficult. In the event that symptoms do appear early on they may sometimes include nausea, vomiting, loss of appetite, weight loss, jaundice of the skin and eyes, early and unexpected development of diabetes and changes in the color of stool or urine. Itchy skin, stomach pain and diarrhea may also be symptoms of pancreatic cancer.

These symptoms are different from one person to another and depending on the location within the pancreas of the cancer. Blockage of the head generally causes jaundice or a yellowing of the skin. On the other hand if the tumor is located in the body or tail it will most likely not cause jaundice but may be likely to produce other pancreatic cancer symptoms such as diarrhea, stomach pain and weight loss.

Because many of these symptoms can also be attributed to other illnesses and diseases the diagnosis of pancreatic cancer may be delayed thus making treatment more difficult. Because pancreatic cancer is a fast spreading cancer it can get to the advanced stages and spread to other organs quite quickly. This also makes treatment more difficult.

In most cases pancreatic cancer symptoms do not appear right away which is another reason why it often is not diagnosed early on. It is very difficult to catch pancreatic cancer in the early stages of the disease.

There are several different treatments available for individuals afflicted with pancreatic cancer and which one is used will vary from one person to the next based on things like age, general health, stage of the disease and personal preference.

If you encounter any of the symptoms associated with pancreatic cancer it is important that you seek the advice of your health care professional. Even if these symptoms are not indicative of pancreatic cancer they are still issues that need to be addressed and treated.

In the event that your symptoms are related to pancreatic cancer the earlier you know about it the better off you will be in relation to treatment. The earlier the diagnosis is made the more likely it will be that treatment will be effective.

Symptoms of pancreatic cancer vary from one person to another dependent upon which area of the pancreas is affected as well as the size of the tumor. For instance a tumor located at the head of the pancreas may create a blockage preventing bile from exiting thus resulting in a yellowing of the skin also known as jaundice.

In other cases such as when tumors may be located within the tail or body of the pancreas other symptoms may be more likely such as stomach pain, diarrhea and weight loss.

Each person is different and the symptoms experienced by one person may be different for someone else. These symptoms also can be different based on the size of the tumor as well. A small tumor may not produce many of these symptoms.

Some of the most common symptoms include weight loss, vomiting, nausea, stomach pain, jaundice or a yellowing of the skin and eyes, early development of diabetes, loss of appetite, itchy skin, diarrhea and changes in the color of stool or urine.

In many cases the symptoms of pancreatic cancer do not present themselves right away in development of pancreatic cancer. For this reason it is very difficult to make an early diagnosis of this type of cancer. Even when symptoms are present early on they are often overlooked or associated with other illnesses or diseases. This also makes discovery of pancreatic cancer difficult.

As with any disease early detection is a very important factor when it comes to treatment options. Pancreatic cancer is no exception however in many cases this cancer is not detected until it is in its later stages and has already spread to other areas of the body. This is partly because it spreads very quickly and also because in many of the diagnosed cases the symptoms were not present until the late stages of development.

Although pancreatic cancer is treatable in later stages it is always best if it can be diagnosed as soon as possible. Since this rarely happens there are still treatment options that can be explored in the later stages however some may not be as effective as if it had been caught sooner and treatment started in the earlier stages.

There are screening tests that can be done to diagnose pancreatic cancer although they are not generally used unless a person is at an increased risk of developing the disease such as a family history of pancreatic cancer or other genetic disorders that may put an individual at a higher risk of contracting the disease.

In general it is always best to seek the advice of a health care professional any time you experience unusual symptoms. Even if these are not symptoms of pancreatic cancer they should be discussed with your doctor so that they may be treated.

Pancreatic cancer is one of the most lethal forms of cancer, with nearly two lakh newly evolved cases detected annually across the globe and virtually that many fatalities occurring due to this disease yearly. Figures reveal that below five percent of individuals detected with having pancreatic cancer survive for above 5 years following detection.

The risk aspects for pancreatic cancer comprise of being diabetic, obese, smoking and a family past of pancreatic cancer.

Though heritable factors appear to don a significant part in pancreatic cancer risk, investigators have stated that solely a miniscule proportion of heritable pancreatic cancer cases could be explicated by presently recognized genes linked with the ailment.

For purposes of identifying more number of genes linked with pancreatic cancer, investigators performed a genome-wide screening of close to 3,900 individuals having the ailment and an evaluation set of 3,934 people in good health.

The outcomes of the study revealed that heritable variants on 3 sites in diverse chromosomes were linked to an augmented risk of developing prostate cancer.

The variants on one of such chromosomes is situated close to CLPTM1L and TERT genes – these duo have been earlier associated with other cancer types, inclusive of brain tumor, lung cancers and melanomas.

Investigators state that further follow-up research into these findings is necessary for confirming the task of such heritable variants in kin-associated pancreatic cancer.

Nutrient-depriving Sutent could assist in combating Rare Pancreatic Cancer

A pill that is capable of hacking off nutritional supply to tumors shows potential as an able treatment for those individuals having rare form of pancreatic cancer.

During the study performed on 171 entrants having advanced staging pancreatic neuroendocrine tumors, the pill Sutent assisted in doubling the time length prior to the ailment worsening.

Cancer progression was observed at between five to six months in case of placebo patients versus between eleven to twelve months in patients on the course of Sutent. Sutent was also observed to curb the chances of death by sixty percent.

Eric Raymond, heading the medical oncology department, Hospital Beaujon, France and part of the research team for this study explained that for the foremost instance in nearly two decades, a new-fangled drug was shown to have benefits among such patients.

Although the rarity of such tumors, they have a life-restricting outcome on those inflicted by them.

Raymond explicated that neuroendocrine tumors (accounting for one percent of all pancreatic cancer cases) has a slower rate of progression as compared to other pancreatic tumors. However, once progression starts, it is swift in spreading.

Those detected in advanced staging of neuroendocrine tumors have hardly any choices. Though chemotherapy is one option, however needs hospitalization and leads to an array of side effects like intense puking, feeling nauseous and hair loss with solely 1 in 3 patients benefiting from this treatment.

Sutent belonging to a group of drugs known as tyrosine kinase inhibitors which has earlier received approval for treatment of advanced staging kidney cancer and GIST (gastrointestinal stromal tumors) has been shown to be useful in treating advanced pancreatic neuroendocrine tumors.

During the novel study, those having advanced pancreatic neuroendocrine tumors were given 3 Sutent pills each morning or placebo tablets. All were additionally offered drugs for treating pain and loose bowels as required.

Analogous side effects were noted when Sutent was offered for treating other cancer types, inclusive of lesser counts of particular blood cells, elevated blood pressure and weariness.

The detrimental occurrences were usually bearable and managed by giving a medicine holiday or reducing the dosage of the drug.

The novel research would be made public during the yearly convene of AAPS or American Association of Pharmaceutical Scientists, in November, in LA. The research shows how TPM or tumor-penetrating particles have been particularly intended to rupture through stubborn blockades and distribute drugs with greater efficacy as compared to the benchmark form of chemotherapy like those that are intravenously administered.

The initiator of the study, an AAPS fellow and a notable university professor from Ohio State University, Jessie L.S. Au, Pharm.D., Ph.D, explicates how the TPM are intended for treating cancer found in the peritoneal cavity. The peritoneal cavity comprises of organs inclusive of the pancreas, that are believed to harbour above 2,50,000 newly evolving cancer cases annually in just the United States. The Pancreatic tumor cells are enclosed by specialized cells that safeguard them from the effects of chemotherapy. Dr. Au further added that their objective was for employing TPM to penetrate this barricade and effectually convey drugs to the tumor cells – that is presently the leading hitch that a physician is faced with during treatment of pancreatic cancer.

The American Cancer Society reveals that pancreatic cancer is the fourth principal cause of cancer in the United States and above eighty percent of the thirty-eight thousand patients that are develop the disease face fatality in a year’s time following detection.

Dr. Au also the co-initiator of Optimum Therapeutics LLC, the company that is carrying forward TPM to clinical trials, expounds the manner in which TPM lets loose what the researchers dub as the ‘smart bomb’ of drugs for creating punctures in the tumors to facilitate easier reach of the TPM to the tumor cells. As soon as the TPM reaches within a tumor, it gradually discharges drug levels that are effectual for a span for many weeks, during which time they target both the swift and sluggish-spreading tumors. As the TPM was intended to freely move around and get to the tumors without getting brushed away by the lymphatic system, they are capable of staying for extended periods of times in the peritoneal cavity and distribute higher concentration drug dosages to the cancer-inflicted organ. It is this two-pronged drug attack strategy that is distinctive to the pancreatic cancer treatment.

With merely a single drug dose of TPM that proves to be similarly effectual as the several chemotherapy injections, TPM is known to deliver lesser degree of toxicity among patients that makes it an increasingly safe choice as compared to the standard course of treatments presently available.

Ze Lu, Ph.D., principal scientist cum project leader stated that on the basis of the heartening outcome in mice that conveyed embeds of human pancreatic cancer, they have been guardedly sanguine that TPM might offer advantages to patients ailing from this disease. He further mentioned that TPM could prove particularly beneficial for those patients in the final stages of the disease.

Dr. Lu stated that the researchers had been putting their unswerving efforts while working on TPM for over a decade and are hopeful of garnering the FDA nod for testing TPM on patients in 2010.

The researchers are working together with the physicians at the Medical University of South California that deem a potent usability of TPM, that alongside treatment of peritoneal metastases would also help in down staging or downsizing the tumors to make them serviceable.

Pain

Nagging pain in the abdomen and back are prevalent pancreatic cancer symptoms. The location of the pancreas is in a region of the abdomen that has interwoven nerves and blood vessels. Pain is experienced when the cancer exerts pressure on these nerves or other organs.

Effectual management and treatment of pancreatic cancer is possible with an array of methods obtainable for treating the cancer-associated pain. These methods comprise of pain-relieving medicines –opioids and non-opioids, radiation therapy, surgical intervention and types of nerve block inclusive of CPB (celiac plexus block) or CPN (celiac plexus neurolysis). Few people opt for supplementing these methods alongside alternative or corresponding therapies like acupuncture, biofeedback, guided imagery and unwinding techniques.

Celiac plexus block (CPB) or celiac plexus neurolysis (CPN)

It is at times carried out for allaying the pain. Such procedures obstruct a cluster of nerves in the abdomen known as the celiac plexus that could transmit feelings of pain to the brain from the abdomen. CPN comprises administering an injection that has an alcohol-based agent for permanent nerve destruction. CPB entails the administration of shots like corticosteroids and de-sensitising medications; however, the effects are transitory lasting for some months and are not proposed for permanent nerve damage.

There are diverse means of carrying out CPB or neurolysis. CPB and CPN could be administered transcutaneously employing a needle introduced into the skin and directed to the correct position with the assistance of CT or computed tomography or endoscopic ultrasound guidance (EUS). A needle could be steered on course employing an endoscope with ultrasound assistance into the celiac plexus location, and corticosteroids along with either alcohol or numbing agents could be infused.

Radio frequency ablation or RFA

This is the latest technique being employed for pain relief wherein radio frequency signals are transmitted via the needle to produce heat just adequate for destroying the nerves. The ideal means of performing nerve block procedure is still unknown. The doctor would carry out a detailed discussion with the patient to ascertain the ideal choice for the patient and would provide a referral to a pain specialist. It is vital to note that these procedures do not offer relief to all, but some would experience a significant lowering of pain.

Stomach Symptoms and Nutrition

Due to an array of reasons, pancreatic cancer could cause unintended weight reduction. At times it could be due to abdominal symptoms like feeling full, bloated, burping, diarrhea and often being constipated. Patients mostly experience sapped appetite, feeling averse to food, feeling nauseous and queasiness. Such symptoms could be either arising due to the cancer or the outcome of the treatments being meted out for the cancer. The optimal strategy for detecting effectual means of symptom management is discussing them with the doctor.

Pancreatic enzymes

These are employed as a means of improving digestion and averting bothersome symptoms like recurrent, greasy faecal movements. These could be occurring among those individuals having an obstruction in-between the pancreas and the intestine or in those that have undergone surgery for partial or total removal of the pancreas. Pancreatic enzymes are administered for replenishing the innate substances usually produced by the pancreas. These enzymes aid in breaking down the proteins, fats and carbohydrates present in the food into smaller sizes for facilitating easier absorption by the intestines. This allows better used of these substances for producing energy in the body.

Few patients might not require any pancreatic enzymes, while there could be others that might require huge amounts of enzymes for relieving the symptoms. Pancreatic enzymes are taken orally normally along with food and water for quite a few times during the day, mostly during meal or snack times. The frequency of the intake of pancreatic enzymes is dependent on the patient’s general health condition and on how favourably one is responding to the treatment. The doctor would issue the amount and the dose of the pills to be taken. Often the patient could get started on a low dosage and slowly raise the dosage on the basis of the patient’s reaction to the treatment and dietetic intake. Pancreatic enzymes might help in controlling the symptoms, though it does not help in curing the condition.

Weariness

Weariness and exhaustion are prevalent signs related to cancer and its treatments. A sense of weariness could range between feeling tired to exhausted, could differ in regularity and mostly have several causes. It is imperative to keep one’s health care providers informed about any feelings of fatigue. There are several resources obtainable that assist a patient in coping with weariness and provide guidance on how to preserve energy.

Dealing with Depressive Tendencies

All who decipher about the presence of cancer have wide-ranging emotions and would undergo varied levels of stress and emotional upheaval during the course of their treatment. These signs and apprehensions generally assuage as the individual adjusts to the detection. Depression is not always experienced by all who are detected with cancer, though the reasons behind depression are unclear. Risk factors could or could not be linked to cancer and few individuals having cancer might have an increased risk of developing depressive tendencies. The signs of severe depression involve depressive moods on majority of the occasions, lack of interest or contentment derived from routine activities, sleep cycle variations, anxiety, feeling sluggish, dearth of concentration and recurrent suicidal and mortality tendencies. Often, these signs are occurring due to a medical condition.

Severe depression could be treated with a potent blend of medications and counseling sessions. Numerous therapies are beneficial in treating cancer-related depression. Therapy programs available in either personal or group settings include support groups, cancer tutoring and classes conducted for honing relaxation skills, coping, yoga and improving meditation.